The bill HF2325 relating to pain assessment for purpose of determining provider payment limited is prohibited (Ryan & Rosenberg, 2015). The commissioner requires county-based purchasing plans, managed care plans, and integrated health partnerships to adhere to this requirement as a form of contract. However, this prohibition is not applicable to: 1) assessing patient satisfaction with pain management with the aim of quality improvement; and (2) pain management as a component of palliative care treatment for patients receiving hospice care and to treat cancer patients (Glied et al. 2015). This paper seeks to discuss the legislative issue regarding the role of a nurse practitioner, and the legislative issues regarding the Collaborative Practice Agreement.
Legislative issues regarding the role of a Nurse Practitioner
The role of nurse practitioners in in providing primary is central to deliberations relating strategies to accomplish the increasing demand for primary care under healthcare reform. Nurse practitioners have played an important role in the provision of primary care to vulnerable populations. Recent healthcare reforms initiative and policies under the Affordable Care Act (ACA) have led to increased demand of nurse practitioners (Buppert, 2014). For instance, the expanded insurance and investment in community health centers, have creased increased need for NPs to address the increasing health needs among vulnerable populations to meet persistent health inequalities.
Legislative issues regarding the Collaborative Practice Agreement (CPA)
The CPA establishes a legal relationship between physicians and pharmacists that enables pharmacists to participate in a collaborative drug therapy management (Dunn, et al. 2015). In Minnesota the CPA are defined under the Minnesota Statute. Pursuant to the CPA, pharmacists in Minnesota may interpret laboratory tests, perform waived laboratory tests and modify medication therapy. CPAs in Minnesota may be between multiple practitioners (defined under subdivision advanced practice nurses, veterans, podiatrists, dentists and physicians) and multiple pharmacists (Roy & Saha, 2016).
Buppert, C. (2014). Nurse practitioner’s business practice and legal guide. Jones & Bartlett Publishers.
Dunn, S. et al. (2015). The role of the clinical pharmacist in the care of patients with cardiovascular disease. Journal of the American College of Cardiology, 66(19), 2129-2139.
Glied, S. et al. (2015). Measuring performance in psychiatry: A call to action.
Ryan, S. F., & Rosenberg, S. (2015). Nurse practitioners and political engagement: Findings from a nurse practitioner advanced practice focus group & national online survey.
Roy, M. N., & Saha, S. S. (2016). Statutory Auditors’ Independence in India: An Empirical Analysis from the Stakeholders’ Interest Perspective. Vikalpa, 41(1), 28-50.